Thymoma treatment cost in Spain typically starts with a consultation with a thoracic surgeon ranging from $200 to $300. Primary treatment involves surgical removal, with prices depending on the surgical technique, hospital tier, and tumor stage. Patients can expect 60-70% savings compared to the United States. Leading medical hubs for these oncology procedures include Barcelona, Madrid, and Pamplona.
Typical Thymoma Treatment Costs in Spain
Bookimed Expert Insight: Advanced surgical cases benefit from JCI-accredited centers like Clinica Universidad de Navarra. They were the first in Spain to receive this quality certification. Patients seeking cutting-edge research should consider Quironsalud Madrid. This facility offers free participation in oncology clinical trials. For pediatric cases, SJD Barcelona Children's Hospital is a top-three European specialist. Centro Médico Teknon remains a preferred choice for high-profile patients needing expert thoracic teams.
The doctor is an oncological surgeon specializing in peritoneal carcinomatosis and is part of the Teknon Oncology Institute’s Carcinomatosis Surgical Group since 2019. She completed her specialization at the Washington Hospital Center under Prof. Paul Sugarbaker and holds American Board of Surgery certification.
She is a member of several prestigious societies, including the American College of Surgeons and the Society of Surgical Oncology. Her academic roles have included Research Director at Inova Fairfax Hospital and Associate Professor positions at Virginia Commonwealth University and Georgetown University.
The doctor is a pediatric oncologist with 37 years of experience, specializing in the treatment of blood disorders and performing procedures like bone marrow transplants and ablation therapy. The doctor is currently the Head of Paediatric Haemato-Oncology at Quironsalud Madrid University Hospital.
With a prolific academic record, the doctor has edited 14 books, contributed to 75 book chapters, and presented at over 200 conferences. The doctor is a member of several professional associations, including the Spanish Association of Paediatric Haematology and the Spanish Association of Paediatric Oncology.
The doctor treats a wide range of conditions, including leukemia, lymphoma, multiple myeloma, and various hematological and autoimmune disorders.
The doctor is responsible for thoracic malignancy management and oversees thoracic cancer trials at the Oncology Department. Their research focuses on optimizing chemotherapy in early-stage disease, evaluating new therapies, exploring pharmacogenomic approaches, integrating immunotherapy for lung cancer, and investigating resistance mechanisms to tyrosine-kinase inhibitors.
Holding a medical degree and a PhD in medical oncology from UAB, the doctor is a member of several prestigious oncology societies, including ESMO, ASCO, and IASLC. They have published numerous peer-reviewed articles and book chapters on thoracic malignancies and have held teaching positions at UAB and UVicc-UCC.
Medical Director of the University of Navarra Clinic
Prof. of hematology and hemotherapy